image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IE
$ 9.47
-4.42 %
$ 915 M
Market Cap
-16.94
P/E
BALANCE SHEET
164 M ASSETS
-0.28%
90.4 M LIABILITIES
17.45%
73.8 M EQUITY
-15.83%
BALANCE SHEET DECOMPOSITION
Balance Sheet Avadel Pharmaceuticals plc
image
Current Assets 134 M
Cash & Short-Term Investments 73.8 M
Receivables 34.1 M
Other Current Assets 26.3 M
Non-Current Assets 30 M
Long-Term Investments 0
PP&E 2.16 M
Other Non-Current Assets 27.9 M
44.92 %20.76 %16.03 %16.97 %Total Assets$164.2m
Current Liabilities 48.8 M
Accounts Payable 7.33 M
Short-Term Debt 582 K
Other Current Liabilities 40.9 M
Non-Current Liabilities 41.6 M
Long-Term Debt 0
Other Non-Current Liabilities 41.6 M
8.11 %45.28 %45.97 %Total Liabilities$90.4m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
ASSETS
Cash & Cash Equivalents 51.4 31.2 74.0 50.7 71.7 9.8 9.3 16.6 39.2 65.1 39.8 6.6 2.7 3.5 8.2 8.7 27.0 26.3 51.8 1.0 4.6 109.6 14.5 5.3 10.1 5.2 7.3 3.8 15.5
Short Term Investments 22.4 73.9 22.5 106.5 149.7 54.4 90.6 77.5 115.0 79.7 53.1 0.4 6.4 21.0 23.2 35.4 10.1 14.7 10.9 82.8 100.8 0 0 0 0 0 0 0 0
Receivables 34.1 13.4 0 0 3.3 8.3 13.9 16.5 17.8 7.5 8.7 21.0 13.2 9.3 11.4 20.3 19.3 12.1 9.0 2.6 8.2 8.4 3.5 7.6 2.6 1.6 3.2 3.3 1.0
Inventory 20.3 10.4 0 0 0 3.6 4.8 6.2 3.3 4.2 6.7 3.8 1.5 1.7 0.9 1.1 1.8 1.8 3.3 1.1 1.6 1.1 0.4 0.6 0.9 0.2 0.8 100 K 0.2
Other Current Assets 6.0 5.3 4.3 35.3 3.3 6.4 6.3 7.2 5.9 10.4 4.1 3.1 1.2 1.2 1.7 1.4 1.0 1.1 1.4 4.6 5.6 1.7 0.3 0.3 0.4 0.7 5.2 7.4 1.1
Total Current Assets 134.2 134.2 100.8 192.5 263.5 82.4 124.9 124.0 181.2 166.3 112.3 33.6 25.1 36.7 45.4 66.8 59.2 56.1 76.8 92.0 120.8 120.7 18.7 13.8 14.1 7.8 16.4 14.6 17.8
PP&E 2.2 13.1 2.6 2.9 3.0 4.2 7.8 3.0 3.3 2.6 1.8 17.4 18.2 19.4 21.4 24.8 27.6 35.1 25.7 22.3 18.2 5.1 3.4 2.7 2.9 3.5 4.6 4.1 1.7
Intangible Assets 0 0 0 0 0 0.8 1.6 92.3 22.8 15.8 28.4 40.1 41.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 K 0.2
Goodwill 16.8 16.8 16.8 16.8 16.8 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 1.2 (22.9) (14.8) (23.1) 8.7 1.4 1.8 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 11.0 0.6 (60.0) 33.8 24.9 39.3 5.7 9.1 7.5 0.2 0.1 6.6 13.9 13.2 7.8 2.7 5.1 10.2 12.4 10.0 6.7 1.4 1.0 1.7 3.4 3.7 4.3 2.7 10.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 164.2 164.7 132.8 247.3 311.6 151.4 190.3 252.1 245.5 215.0 174.2 116.3 117.3 69.4 74.6 94.3 91.9 101.4 114.9 124.4 145.6 127.3 23.1 18.1 20.4 14.9 25.3 21.5 29.9
LIABILITIES
Accounts Payable 7.3 11.4 7.9 7.7 2.9 6.1 3.5 7.5 7.1 5.0 8.0 5.1 3.6 3.9 4.9 6.4 5.8 8.6 9.7 11.5 9.7 4.4 1.3 1.2 1.5 1.5 2.6 2.5 3.1
Short Term Debt 0.6 1.9 39.6 1.8 0.9 1.3 0.1 0.1 0.3 0.4 42.4 26.3 3.5 2.2 2.4 0.9 0.8 1.0 0.4 0.8 0.6 0.3 0.9 0.8 0.6 0.5 0.4 0.4 0.4
Other Current Liabilities 40.9 23.6 8.3 11.5 11.2 28.6 34.6 76.7 51.6 34.3 11.5 9.2 6.4 9.3 9.5 11.7 12.9 12.5 10.6 12.4 10.6 3.6 2.5 3.4 2.4 1.4 1.4 1.2 1.3
Total Current Liabilities 48.8 36.9 55.8 21.0 15.1 36.0 38.4 86.2 62.4 48.8 70.8 40.6 14.4 18.3 19.4 22.9 20.3 25.0 21.3 24.9 23.3 17.9 6.5 6.5 6.1 3.5 4.4 4.1 4.8
Long Term Debt 0 34.5 92.4 144.1 130.1 124.0 115.7 0.2 0.5 0.7 76.1 66.3 33.5 1.9 1.7 3.0 2.4 2.4 3.1 3.0 2.4 1.9 1.5 0.9 1.6 2.1 2.9 3.0 1.7
Deferred Tax Income 0 0 71.3 0 0 0 0 72.3 134.3 1.4 0 8.9 26.8 0 0 0 0 (0.3) 0 0 (0.9) (14.2) 0 0 0 0 0 0 0
Other Liabilities 41.6 5.7 5.7 3.9 4.2 20.6 33.4 81.0 140.4 94.4 2.3 16.0 24.7 17.8 14.0 17.5 20.5 19.0 17.4 9.8 2.3 1.2 2.7 3.3 1.8 0.3 0.3 100 K 0.3
Total Liabilities 90.4 77.0 153.9 169.0 149.4 180.6 187.5 167.5 203.4 147.1 149.3 125.8 86.8 39.6 38.3 49.4 43.3 46.8 41.9 37.7 28.9 35.2 10.8 10.6 9.5 5.9 7.5 7.2 6.8
EQUITY
Common Stock 1.0 0.9 0.6 0.6 0.6 0.4 0.4 0.4 0.4 6.3 6.2 3.7 3.7 3.6 3.6 3.5 3.5 3.5 3.5 3.4 3.1 3.1 2.4 2.4 2.4 2.0 2.0 0 0
Retained Earnings (794.3) (745.5) (585.2) (447.8) (384.2) (391.2) (358.0) (263.7) (319.8) (279.8) (320.5) (235.5) (192.6) (189.4) (180.6) (171.6) (160.2) (148.1) (110.4) (75.2) (47.8) (59.9) (56.4) (59.4) (56.5) (47.1) (40.4) (32.5) (25.7)
Other Accumulative Comprehensive Income/Loss (24.6) (23.2) (26.3) (23.9) (21.1) (22.8) (23.4) (23.3) (23.6) (22.7) (7.4) 10.8 10.3 10.1 10.9 14.5 12.2 14.1 6.5 (2.7) 13.0 1.2 (4.9) (6.6) (6.1) (5.2) (3.2) (5.5) (5.7)
Total Equity 73.8 87.7 (21.1) 78.2 162.3 (29.2) 2.8 84.6 42.1 67.9 24.9 (9.5) 30.5 29.8 36.3 44.9 48.5 54.6 73.0 86.7 116.8 92.1 12.3 7.5 10.9 9.1 17.8 14.3 23.1
Total Liabilities and Equity 164.2 164.7 132.8 247.3 311.6 151.4 190.3 252.1 245.5 215.0 174.2 116.3 117.3 69.4 74.6 94.3 91.9 101.4 114.9 124.4 145.6 127.3 23.1 18.1 20.4 14.9 25.3 21.5 29.9
SHARES OUTSTANDING
Common Shares Outstanding 95.1 80.2 60.1 58.5 53.0 37.4 37.3 40.5 41.2 40.6 36.2 25.4 24.9 24.7 24.4 24.2 24.1 24.0 23.8 23.0 21.5 17.8 16.2 16.2 15.3 12.9 12.0 10.5 8.6